Survival associated with treatment vs observation of localized prostate cancer in elderly men (Reprinted from JAMA, vol 296, 2006)

被引:222
作者
Wong, Yu-Ning
Mitra, Nandita
Hudes, Gary
Localio, Russell
Schwartz, J. Sanford
Wan, Fei
Montagnet, Chantal
Armstrong, Katrina
机构
[1] Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA
[2] Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA
[3] Univ Penn, Dept Biostat & Epidemiol, Div Gen Internal Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[5] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 296卷 / 22期
关键词
D O I
10.1001/jama.296.22.2683
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Prostate-specific antigen screening has led to an increase in the diagnosis and treatment of localized prostate cancer. However, the role of active treatment of low- and intermediate-risk disease in elderly men is controversial. Objective To estimate the association between treatment ( with radiation therapy or radical prostatectomy) compared with observation and overall survival in men with low- and intermediate-risk prostate cancer. Design and Setting Observational US cohort from Surveillance, Epidemiology, and End Results Medicare data. Patients At total of 44 630 men aged 65 to 80 years who were diagnosed between 1991 and 1999 with organ-confined, well-or moderately differentiated prostate cancer and who had survived more than a year past diagnosis. Patients were followed up until death or study end ( December 31, 2002). Patients were classified as having received treatment ( n= 32 022) if they had claims for radical prostatectomy or radiation therapy during the first 6 months after diagnosis. They were classified as having received observation ( n= 12 608) if they did not have claims for radical prostatectomy, radiation, or hormonal therapy. Patients who received only hormonal therapy were excluded. Main Outcome Measure Overall survival. Results At the end of the 12-year study period, 4663 men ( 37%) in the observational group and 7639 men ( 23.8%) in the treatment group had died. The treatment group had longer 5- and 10-year survival than the observation group. After using propensity scores to adjust for potential confounders ( tumor characteristics, demographics, and comorbidities), there was a statistically significant survival advantage associated with treatment ( hazard ratio, 0.69; 95% confidence interval, 0.66-0.72). A benefit associated with treatment was seen in all subgroups examined, including older men ( aged 75-80 years at diagnosis), black men, and men with low- risk disease. Conclusions This study suggests a survival advantage is associated with active treatment for low- and intermediate-risk prostate cancer in elderly men aged 65 to 80 years. Because observational data cannot completely adjust for potential selection bias and confounding, these results must be validated in randomized controlled trials of alternative management strategies in elderly men with localized prostate cancer.
引用
收藏
页码:2683 / 2693
页数:11
相关论文
共 36 条
[1]   20-year outcomes following conservative management of clinically localized prostate cancer [J].
Albertsen, PC ;
Hanley, JA ;
Fine, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17) :2095-2101
[2]   Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer [J].
Albertsen, PC ;
Hanley, JA ;
Gleason, DF ;
Barry, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11) :975-980
[3]   30-day mortality and major complications after radical prostatectomy: Influence of age and comorbidity [J].
Alibhai, SMH ;
Leach, M ;
Tomlinson, G ;
Krahn, MD ;
Fleshner, N ;
Holowaty, E ;
Naglie, G .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (20) :1525-1532
[4]   Frozen section diagnosis of metastatic prostate adenocarcinoma in pelvic lymphadenectomy compared with nomogram prediction of metastasis [J].
Beissner, RS ;
Stricker, JB ;
Speights, VO ;
Coffield, KS ;
Spiekerman, AM ;
Riggs, M .
UROLOGY, 2002, 59 (05) :721-725
[5]   Radical prostatectomy versus watchful waiting in early prostate cancer [J].
Bill-Axelson, A ;
Holmberg, L ;
Ruutu, M ;
Häggman, M ;
Andersson, SO ;
Bratell, S ;
Spångberg, A ;
Busch, C ;
Nordling, S ;
Garmo, H ;
Palmgren, J ;
Adami, HO ;
Norlén, BJ ;
Johansson, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19) :1977-1984
[6]  
BRIGANTI A, 2006, EUR UROL, V175, P721
[7]   Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo osteoporosis epidemiology study [J].
Chang, KP ;
Center, JR ;
Nguyen, TV ;
Eisman, JA .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (04) :532-536
[8]   RESULTS OF CONSERVATIVE MANAGEMENT OF CLINICALLY LOCALIZED PROSTATE-CANCER [J].
CHODAK, GW ;
THISTED, RA ;
GERBER, GS ;
JOHANSSON, JE ;
ADOLFSSON, J ;
JONES, GW ;
CHISHOLM, GD ;
MOSKOVITZ, B ;
LIVNE, PM ;
WARNER, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (04) :242-248
[9]   Critical evaluation of hormonal therapy for carcinoma of the prostate [J].
Chodak, GW ;
Keane, T ;
Klotz, L ;
Hormone Therapy Study Grp .
UROLOGY, 2002, 60 (02) :201-208
[10]   EFFECTIVENESS OF ADJUSTMENT BY SUBCLASSIFICATION IN REMOVING BIAS IN OBSERVATIONAL STUDIES [J].
COCHRAN, WG .
BIOMETRICS, 1968, 24 (02) :295-&